Owl Creek Wealth Partners LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 2133805
DENVER, CO
Position in ARWR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$36,679
New position
Shares Held
585
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Owl Creek Wealth Partners LLC holds $572,123 across 36 Biotechnology names. ARWR ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
256 | $114,314 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
113 | $87,308 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
130 | $43,013 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
585 | $36,679 | |
| 5 | ARGX |
Argenx SE
|
47 | $34,321 | |
| 6 | MRNA |
Moderna, Inc.
|
551 | $27,990 | |
| 7 | GMAB |
Genmab A/S
|
882 | $23,664 | |
| 8 | INCY |
Incyte Corp
|
250 | $23,530 |
All Filings in ARWR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,679 | 585 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||